INFLAMMATORY BOWEL DISEASES

Scope & Guideline

Empowering researchers with impactful findings.

Introduction

Welcome to the INFLAMMATORY BOWEL DISEASES information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of INFLAMMATORY BOWEL DISEASES, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1078-0998
PublisherOXFORD UNIV PRESS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1995 to 2024
AbbreviationINFLAMM BOWEL DIS / Inflamm. Bowel Dis.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressJOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513

Aims and Scopes

The journal 'Inflammatory Bowel Diseases' is dedicated to the comprehensive exploration and dissemination of research related to inflammatory bowel diseases (IBD), particularly Crohn's disease and ulcerative colitis. Its aims encompass a broad spectrum of topics that include clinical management, epidemiology, pathophysiology, and advancements in therapeutic approaches.
  1. Clinical Management and Therapeutics:
    The journal focuses on clinical strategies for managing IBD, including the evaluation and effectiveness of various treatment modalities such as biologics, immunomodulators, and surgical interventions.
  2. Epidemiology and Public Health:
    Research articles often address the epidemiological trends, risk factors, and healthcare utilization patterns associated with IBD, contributing to a better understanding of the disease burden across different populations.
  3. Pathogenesis and Molecular Mechanisms:
    The journal emphasizes studies exploring the underlying biological mechanisms of IBD, including genetic, immunological, and microbiome-related factors that contribute to disease development and progression.
  4. Patient-Centered Outcomes and Quality of Life:
    There is a strong focus on understanding the impact of IBD on patients' quality of life, including studies on psychological aspects, social determinants of health, and patient-reported outcomes.
  5. Innovative Research Techniques:
    The journal encourages the use of advanced research methodologies, including machine learning, biomarker discovery, and novel therapeutic approaches, to enhance the understanding and treatment of IBD.
Recent publications in 'Inflammatory Bowel Diseases' have highlighted several emerging themes that reflect the evolving landscape of research in this field. These trends indicate a shift towards more innovative, personalized, and integrative approaches to IBD management.
  1. Microbiome Research:
    There is a growing emphasis on the role of the gut microbiome in IBD, with studies exploring microbial signatures, their impact on disease activity, and potential therapeutic applications of microbiome modulation.
  2. Telemedicine and Digital Health:
    The integration of telemedicine into IBD management has emerged as a significant theme, particularly in response to the COVID-19 pandemic, highlighting the need for accessible care and patient engagement.
  3. Psychosocial Factors and Mental Health:
    Research focusing on the psychological impact of IBD, including anxiety, depression, and patient coping strategies, has gained traction, recognizing the importance of mental health in disease management.
  4. Precision Medicine and Biomarkers:
    The journal is increasingly publishing studies on precision medicine approaches, including the identification of biomarkers for treatment response, which aim to tailor therapies to individual patient profiles.
  5. Innovative Therapeutic Strategies:
    There is a surge in research related to novel therapeutics, including the use of biologics, small molecules, and combination therapies, indicating a shift towards more effective and targeted treatment options.

Declining or Waning

While the journal continues to cover a wide range of topics related to inflammatory bowel diseases, certain themes have shown a decline in focus over recent years. This may reflect shifts in research priorities or changes in the clinical landscape.
  1. Traditional Dietary Interventions:
    Research on conventional dietary interventions in IBD, such as low-residue diets, has decreased, possibly due to a growing emphasis on personalized nutrition and the microbiome's role in disease management.
  2. Opioid Use Management:
    The frequency of studies specifically addressing opioid use management in IBD patients has waned, perhaps as alternative pain management strategies and the opioid crisis have shifted research focus.
  3. Classic Surgical Techniques:
    There seems to be a diminishing emphasis on traditional surgical approaches for IBD, as newer minimally invasive techniques and biologic therapies gain prominence in clinical practice.
  4. Epidemiological Studies in Specific Regions:
    Research focusing on localized epidemiological studies has decreased, indicating a potential shift towards more global or multi-center studies that consider diverse populations.
  5. Historical Perspectives on IBD Treatment:
    The journal has seen a reduction in articles discussing historical treatment methodologies, as the focus shifts toward current and future therapeutic innovations.

Similar Journals

GUT

Empowering Clinicians and Researchers in Gastroenterology
Publisher: BMJ PUBLISHING GROUPISSN: 0017-5749Frequency: 12 issues/year

GUT is a premier journal in the field of gastroenterology, published by the esteemed BMJ Publishing Group. With a rich history dating back to 1960 and an impressive convergence of research expected to continue through 2024, GUT has established itself as a cornerstone of academic discourse in the gastrointestinal sciences. The journal boasts a remarkable impact factor, positioning it in the Q1 category for gastroenterology with an outstanding rank of #3 out of 167 in its Scopus ranking, reflecting its 98th percentile status among peers. Although it does not currently offer open access options, GUT remains dedicated to disseminating high-quality research, reviews, and clinical studies that advance the understanding of digestive health. Published in the United Kingdom, GUT serves as an essential resource for researchers, clinicians, and students aiming to stay at the forefront of innovations and developments in the field.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Driving excellence in gastrointestinal and liver disease studies.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

Journal of Crohns & Colitis

Pioneering research for a healthier gut.
Publisher: OXFORD UNIV PRESSISSN: 1873-9946Frequency: 12 issues/year

Journal of Crohns & Colitis, published by Oxford University Press, is a premier academic platform dedicated to advancing research in the field of gastroenterology. With an impressive impact factor placing it in the Q1 quartile for both gastroenterology and miscellaneous medicine, this journal stands out as a vital resource for researchers, practitioners, and students interested in inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. The journal has successfully converged academic discourse since its inception in 2007, consistently ranking among the top publications in its category, reflecting its reputation and influence within the scientific community. Located in the United Kingdom, the journal offers a platform for disseminating high-quality research and innovative clinical studies, thereby enhancing our understanding and management of gastrointestinal disorders. Researchers are encouraged to submit their findings to contribute to this pivotal dialogue in the field.

AMERICAN JOURNAL OF GASTROENTEROLOGY

Transforming Patient Care Through Cutting-Edge Research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0002-9270Frequency: 12 issues/year

AMERICAN JOURNAL OF GASTROENTEROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of gastroenterology and hepatology, boasting a notable impact factor that underscores its influence in the medical community. With an ISSN of 0002-9270 and an E-ISSN of 1572-0241, this journal has a long-standing tradition since its inception in 1938, officially recognized from the year 1947 to 2024. It holds esteemed positions in Q1 quartiles for both gastroenterology and hepatology as of 2023, reflecting its high-quality research output and its crucial role in advancing medical knowledge. Ranked 13th out of 167 in the field of Gastroenterology and 13th out of 82 in Hepatology by Scopus, it serves as an essential resource for researchers, professionals, and students alike, fostering an environment for the dissemination of groundbreaking studies and insights in gastrointestinal health. Its comprehensive focus on clinical and translational aspects aims to illuminate the complexities of digestive diseases, promising to contribute significantly to advancements in patient care and treatment methodologies.

International Journal of Rheumatic Diseases

Advancing understanding in rheumatology.
Publisher: WILEYISSN: 1756-1841Frequency: 12 issues/year

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

Gastroenterology Report

Cutting-edge Insights for the Future of Gastrointestinal Medicine
Publisher: OXFORD UNIV PRESSISSN: 2052-0034Frequency: 1 issue/year

Gastroenterology Report, published by Oxford University Press, is a leading Open Access journal dedicated to advancing the field of gastroenterology. Since its inception in 2013, this journal has become a vital resource for researchers, clinicians, and students, providing them with access to high-quality, peer-reviewed articles that span a wide range of topics in gastrointestinal health and disease. With an impressive Q2 ranking in gastroenterology and holding a position of #66 out of 167 in Scopus rankings, it reflects the growing impact and relevance of its published research. The objective of the Gastroenterology Report is to foster interdisciplinary collaboration and disseminate crucial findings that can improve patient outcomes and shape future studies. As the journal converges its efforts from 2014 to 2024, it continues to strengthen its role as a premier outlet for innovative research and clinical advances in the dynamic field of gastroenterology.

Gastroenterology

Elevating Knowledge in Gastroenterology and Hepatology
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0016-5085Frequency: 12 issues/year

Gastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.

DISEASES OF THE COLON & RECTUM

Your Gateway to Colorectal Research Excellence
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0012-3706Frequency: 12 issues/year

DISEASES OF THE COLON & RECTUM, published by Lippincott Williams & Wilkins, stands as a critical resource in the field of gastroenterology, focusing on the comprehensive study and management of colorectal diseases. With an ISSN of 0012-3706 and an E-ISSN of 1530-0358, this journal serves a diverse audience, including researchers, clinicians, and students interested in the latest advancements in this vital area of medicine. Recognized for its quality, it holds a Q2 ranking in both Gastroenterology and Miscellaneous Medicine categories for 2023 and is positioned at the 58th percentile within its Scopus rank. Since its inception in 1958, the journal has dedicated itself to disseminating original research, reviews, and clinical studies, providing a platform for sharing innovative findings that drive the field forward. While it is not an open access journal, its content remains pivotal for professionals looking to stay apprised of evidence-based practices and emerging trends in colorectal health. With ongoing contributions expected until 2024, DISEASES OF THE COLON & RECTUM continues to be an indispensable source of knowledge for anyone engaged in the intricacies of digestive health.

DIGESTION

Innovating clinical practices for enhanced digestive health.
Publisher: KARGERISSN: 0012-2823Frequency: 6 issues/year

DIGESTION is a prestigious journal dedicated to advancing the field of gastroenterology, published by KARGER, a renowned publisher based in Switzerland. With a rich history dating back to 1896, this journal has continuously evolved and serves as a vital platform for researchers, professionals, and students alike. DIGESTION is recognized for its scholarly contributions, holding an impressive rank of 23 out of 167 in the Scopus database, placing it within the top 14% of gastroenterology journals, as evidenced by its Q2 classification. The journal's commitment to high-quality research is reflected in its wide-ranging scope, addressing various aspects of digestive health, clinical practices, and innovative therapies. Though not an open-access journal, it provides comprehensive access options that ensure the dissemination of crucial research findings to the global community. As we move towards 2024, DIGESTION continues to facilitate dialogue and insights in gastroenterological research, making it an indispensable resource for those in the field.

Clinical and Experimental Gastroenterology

Exploring the frontiers of gastroenterology for better patient outcomes.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7023Frequency: 1 issue/year

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.